Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Alnylam Pharmaceuticals, BioMarin Pharmaceutical Inc., and Cytonet Set to Speak on Conducting Effective Orphan Drug Research
CP Wire
Friday, November 16, 2012 - 10:27am
tags:
Alnylam, Cytonet, Biomarin, orphan drugs
Glaxo Pays $90 Million to Settle States’ Avandia Claims
Bloomberg
Friday, November 16, 2012 - 10:24am
tags:
GSK, settlements, Avandia
Lipitor Whistleblower Suit Against Pfizer Is Dismissed
Pharmalot
Friday, November 16, 2012 - 10:23am
tags:
whistleblower lawsuits, Pfizer, Lipitor
Pacific BioLabs Acquires Bay Bioanalytical Laboratory
CP Wire
Friday, November 16, 2012 - 10:22am
tags:
M&A, Bay Bioanalytical Laboratory, Pacific BioLabs
Allergan to pay $350 mln for SkinMedica skin products co.
Reuters
Friday, November 16, 2012 - 10:15am
tags:
Allergan, M&A, SkinMedica
Pfizer's once-daily Lyrica trial fails to meet goal
Reuters
Friday, November 16, 2012 - 10:14am
tags:
Pfizer, Lyrica, epilepsy
AstraZeneca's Forxiga For Type 2 Diabetes Is A Potential Blockbuster
Seeking Alpha
Friday, November 16, 2012 - 10:13am
tags:
AstraZeneca, Forxiga, diabetes, Dapagliflozin
Novartis wins EU okay for first meningitis B vaccine
Reuters
Friday, November 16, 2012 - 10:12am
tags:
Novartis, EMA, Europe, meningitis B, vaccines, Bexsero
Biocon, Bristol-Myers in deal for oral insulin drug
Reuters
Friday, November 16, 2012 - 10:10am
tags:
Biocon, Bristol-Myers Squibb, insulin, diabetes, IN-105
Dynavax Shares Pummelled After FDA Panel
Motley Fool
Friday, November 16, 2012 - 10:10am
tags:
FDA, advisory panels, Dynavax, Heplisav, hepatitis B, vaccines
Reckitt trumps Bayer with $1.4 bln bid for Schiff
Reuters
Friday, November 16, 2012 - 10:09am
tags:
Reckitt Benckiser, Bayer AG, Schiff, M&A
Trovagene's Foray Into The Conventions Of Molecular Diagnostics
Seeking Alpha
Thursday, November 15, 2012 - 4:38pm
tags:
TrovaGene, molecular diagnostics, Sequenom, Hologic, Quest Diagnostics
Are Arena and VIVUS Frenemies?
Motley Fool
Thursday, November 15, 2012 - 4:36pm
tags:
Arena Pharmaceuticals, Vivus, Qsymia, Belviq, obesity
5 Drug Hopefuls That Are Going to Change Your Life: Part 1
Motley Fool
Thursday, November 15, 2012 - 4:25pm
tags:
BG-12, Biogen Idec, MS, multiple sclerosis
Synergy Pharma shoots higher on plecanatide plans
Yahoo/AP
Thursday, November 15, 2012 - 11:59am
tags:
plecanatide, Synergy Pharmaceuticals
After The Bloodbath, Where Does Pharmacyclics Go From Here?
Seeking Alpha
Thursday, November 15, 2012 - 11:58am
tags:
Pharmacyclics, earnings
MAP Pharma's Awkward FDA Silence
TheStreet.com
Thursday, November 15, 2012 - 11:57am
tags:
FDA, MAP Pharmaceuticals, migraines, Levadex
Upstart Valor launches with plans to develop armed antibody cancer drugs
Fierce Biotech
Thursday, November 15, 2012 - 11:35am
tags:
Valor, armed-antibodies, cancer
Tranzyme Stomach Paralysis Drug Comes Up Short
TheStreet.com
Thursday, November 15, 2012 - 11:33am
tags:
stomach paralysis, Tranzyme
Alnylam: No Approved Drugs, No Promising Candidates, No Justification For $1 Billion Valuation
Seeking Alpha
Thursday, November 15, 2012 - 11:32am
tags:
Alnylam

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.